In February 2020 your community will have the chance to hear from two remarkable frontline workers who are not only dealing with the physical, mental and familial impacts of this unwieldly experiment, but have documented and recorded what the majority non-cannabis using public is kept in the dark about. The failed economic prosperity, the escalating and overwhelming mental and community health burden and drug driving explosions are only the tip of the iceberg of issues presenting.

These evidence-based presentations are a must see for all politicians, policy- makers, medical staff of all persuasion, community leaders, educators, emergency services and civic leaders.

The future well-being of not only community, but more so, families and our very vulnerable emerging generation deserve the best protective health, safety and potential developing policies. Legalizing Cannabis will diminish community health and resiliency, not build it!

The Tour will commence 8th of February and visit key cities on the East Coast and Tasmania. To find out more or request a presentation to your community organisation/group, contact us on 1300 975 002 or email This email address is being protected from spambots. You need JavaScript enabled to view it.

#preventdontpromote

 

Download 2020 Cannabis Conundrum Tour Flyer

View 2020 Cannabis Conundrum Upcoming Events

 

andatech logoProudly sponsored by ANDATECH

Drug and Alcohol Test Equipment

Andatech offers a range of drug and alcohol test devices suitable for both consumer and workplace use. Our alcohol breath testers and drug test kits meet Australian Standards requirements and are used widely for a range of applications. This includes personal use, workplace employee testing, law enforcement and medical use.

 

Highlights

  • We estimate that >2 million U.S. adults who have reported ever using marijuana have cardiovascular disease.
  • Observational studies have suggested an association between marijuana use and a range of cardiovascular risks.
  • Marijuana is becoming increasingly potent, and smoking marijuana carries many of the same cardiovascular health hazards as smoking tobacco.
  • Few randomized clinical trials have been conducted or are planned to explore the effects of marijuana on cardiovascular risk.
  • Screening and testing for use of marijuana are encouraged in clinical settings, especially in the care of young patients presenting with cardiovascular disease

For More

 Colorado, Washington, Nevada, and  Massachusetts Post Increases in Youth Use Over Previous Year

(Alexandria, VA) - Today, state-level data from the National Survey on Drug Use and Health, the most authoritative study on drug use conducted by the Substance Abuse and Mental Health Administration (SAMHSA), finds that marijuana use in "legal" states among youth, young adults, and the general population continued its multi-year upward trend in several categories. 

Additionally, use rates in "legal" states continue to drastically outstrip the use in states that have not legalized the drug. Highlights include:

  • Past-month marijuana use among young people aged 18-25 in "legal" states has increased 8 percent in the last year (30.94% versus 28.62%). Use in this age group is 50 percent higher in "legal" states than in non-legal states (30.94% versus 20.66%).
     
  • Past-month youth use (aged 12-17) in states with commercial sales continued its recent upward trend. Since last year, "legal" Washington experienced the largest surge in past month youth use with an 11 percent increase (9.94% versus 8.96%). Colorado experienced a four percent increase (9.39% versus 9.02%). 
     
  • Massachusetts overtook Colorado as the top-ranking state for overall first-time use, which is now number two.
     
  • Past-month youth use in "legal" states is 40% higher than in non-legal states (8.92% versus 6.26%). Past-year youth use in "legal" states is roughly 30% higher than in non-legal states (15.82% versus 12.10%).
     
  • First-time youth use in "legal" states is 30% higher than non-legal states (6.96% versus 5.38%)

"This data show the marijuana industry is achieving its goal of hooking our kids on today's highly potent marijuana," said Dr. Kevin Sabet, president of Smart Approaches to Marijuana (SAM) and a former senior drug policy advisor to the Obama Administration. "As we learned just this week from the Monitoring the Future survey, the number of young people who perceive marijuana as being harmful is at a historic low. Given the recent data linking high potency marijuana with serious mental health issues, addiction, and future substance abuse, this is extremely concerning. We call on Congress and the President now to stop helping the pot industry and commence a science based information campaign about the dangers of today's marijuana products."

Research has shown that the adolescent brain - particularly the part of the brain that regulates planning for complex cognitive behavior, personality expression, decision making and social behavior - is not fully developed until the early to mid-20s. Developing brains are especially susceptible to all of the negative effects of marijuana and other drug use. Given the drastic increase in marijuana use we are witnessing in this age group in "legalized" states, there should be great cause for concern. 

"This data, combined with yesterday's Monitoring the Future study, and the statements from the overwhelming majority of doctors, educators, substance abuse professionals and parents, must be our guide to changing the current discourse," continued Dr. Sabet. "We cannot allow Big Marijuana to continue to deceive the American people for their bottom line." 

 

Dr Kevin Sabet – Co-Founder,

 

sam

Am J Case Rep 2019; 20:1874-1878  DOI: 10.12659/AJCR.919545
CASE REPORT: We report a death of an 11-day-old white female neonate due to acute marijuana toxicity. She died of extensive necrosis and hemorrhage of the liver and adrenals due to maternal use of marijuana.
CONCLUSIONS: This case is unique in that other possible causes of death can be eliminated. With growing use of marijuana by pregnant women and increases in newborn drug screening of umbilical cord homogenate, more cases of neonatal death due to acute marijuana toxicity could be discovered.

For Full Paper

Warning: Graphic and disturbing content

The court heard cannabis-induced psychosis, not a major mental disorder, spurred the brutal death of 67-year-old John Kehl by his then 31-year-old son Adam.

Adam Kehl voluntarily entered a plea of guilty to manslaughter in front of The Honourable Michelle Fuest in Barrie court on Nov. 22 who called the incident "horrifying and unusually brutal."

https://www.thespec.com/news-story/9737249-cannabis-induced-psychosis-blamed-in-beheading-of-father-at-muskoka-cottage/

The following (not publicly reported) heinous drug-induced behaviour happened in Pueblo, Colorado earlier November 2019

A young man who used a cannabis wax and then experienced an excited delirium episode in which he ran in on coming traffic swinging a metal rod at cars.  He was tazed and tackled by police and came in with 3 police officers and 5 paramedics working to hold him down.  Prior to arrival EMS had given him 50 mg of diphenhydramine, 5 mg of Haldol, and 2 mg of Versed and he continued to be that combative.  On arrival here he took all of the aforementioned personnel plus 3 of our security officers to hold and move him to the bed and hold him down.  I gave 10 mg of Versed with plans to likely need to intubate him.  He became more relaxed and calm following, never required intubation.  UDS only positive for cannabis.  He developed rhabdo and was admitted to the peds service for this following.

Patient was 17 years old

“High potency” is typically 10-12% THC.  That simply does not exist in Colorado.  It’s too weak.

Our kids have access to 17-20% THC easily to smoke as well as concentrates pushing 40-60% THC as well as the wax/shatters which are 90%+ THC.  Easily and readily available to adolescents in Colorado.

We are at a tipping point in the US with our kids using these products.

Colorado Medical Doctor 

Expert Tour Presenters are…

Dr. Karen Randall FAAEM

  • Chairman of the Board, SCEMA

  • VP of Case Management, SCEMA

  • Certified in Cannabis Science & Medicine

    Dr. Karen Randall trained in family medicine, pediatrics and emergency medicine.

    She worked at Henry Ford Hospital in Detroit teaching emergency medicine in a large academic program and was teacher of the year several times.

    Dr. Karen is part of a large emergency medicine group called Southern Colorado Emergency Medicine Associates (SCEMA). She is both chairman of the board of SCEMA, and the Vice President of case management.

    With regards to cannabis - Dr. Karen is certified in Cannabis Science & Medicine through the University of Vermont. She has spoken internationally and across the US about the harms of cannabis.

    Dr. Karen recently published an article about emergency medicine presentations in Missouri Medicine.

    In her spare time, Dr. Karen, takes care of medically needy rescue dachshunds that no one wants. She says they are a handful, but they keep her grounded.

Lynn Riemer (A.C.T. on Drugs)

Lynn Riemer has a regional and National reputation as a speaker, trainer, and advocate on the issues related to substance abuse.

As an experienced chemist (DEA) and prior member of the North Metro Drug Task Force in Colorado, her experience and engaging style brings a real, personal, and vivid face to the issues presented by illicit drug use.

Lynn speaks regularly with students, community child advocacy groups, industrial and professional groups, and employees of local and State governmental agencies. She addresses drug awareness, recognition, and prevention.

While working with the North Metro Drug Task Force she developed intensive programs used to train emergency and community service workers in the handling of hazardous waste and the management of clandestine labs.

Additionally, she has been a member of governmental committees to create regulations for meth clean up in the state of Colorado.

Lynn has co-chaired the Drug Endangered Children program, as well as worked to create new laws protecting children who are living in homes where meth is manufactured.

She is a co-author of the book “The Methamphetamine Crisis: Strategies to Save Addicts, Families, and Communities” and received the Community Champion for Children Award from Adams & Broomfield CASA in 2010.

In 2018 Lynn received the 7Everyday Hero Award (presented to Coloradans who are making a difference in their community).